In late 2025, the American Urological Association (AUA) released updated guidance on vasectomy. The newest release updates the previous 2012 version, based on a comprehensive literature search that spanned 1990 through January 2024. The 2026 version features 26 statements related to vasectomy, including statements on patient evaluation and counseling, skin preparation, and repeat vasectomy.
The 2026 vasectomy guideline features 26 statements; the 2012 guideline featured 15 statements. Additionally, the 2026 update is organized into twice as many sections (Patient Evaluation and Counseling, Peri-Procedural Antibiotics, Skin Preparation, Anesthetics and Peri-Procedural Pain Management, Vas Isolation, Vas Occlusion, Vasectomy Complications, Post-Vasectomy Semen Analysis, Repeat Vasectomy, and Fertility Restoration After Vasectomy) compared to the five sections in the 2012 guideline (Preoperative Practice, Anesthesia for Vasectomy, Vas Isolation, Vas Occlusion, and Postoperative Practice).
Below, you'll find key comparisons between the two versions of the AUA vasectomy guidelines.
Guidelines Referenced:
- Vasectomy: AUA Guideline
- Publication: 2012
- Full Text
AUA Vasectomy Guidelines – Key Comparisons (2012-2026)
In addition to the changes outlined above, The following table compares the updated recommendations in the 2026 version to the 2012 version. To view the complete AUA Vasectomy guidelines, view the full-text versions using the links featured above.
| Topic | 2012 AUA Vasectomy Guideline | 2026 AUA Vasectomy Guideline |
|---|---|---|
| Pre-Operative Consultation | A preoperative interactive consultation should be conducted, preferably in person. If an in-person consultation is not possible, then preoperative consultation by telephone or electronic communication is an acceptable alternative. | Clinicians should provide pre-operative consultation for the patient considering vasectomy. Consultation may be accomplished virtually or in person. |
| Links to Cancer, Cardiovascular Disease, etc. | Clinicians do not need to routinely discuss prostate cancer, coronary heart disease, stroke, hypertension, dementia or testicular cancer in pre-vasectomy counseling of patients because vasectomy is not a risk factor for these conditions. | Clinicians may inform patients that no causal link has been established between vasectomy and the development of prostate cancer. Clinicians may inform patients that no causal link has been established between vasectomy and development of high-grade prostate cancer or increased prostate cancer mortality. Clinicians may inform patients that no causal link has been established between vasectomy and the risk of cardiovascular disease. Clinicians may inform patients that no causal link has been established between vasectomy and nephrolithiasis. |
| Risk of Infection | Prophylactic antimicrobials are not indicated for routine vasectomy unless the patient presents a high risk of infection. | Clinicians may forego peri-procedural antibiotics for patients undergoing vasectomy unless the patient is at high risk of infection. |
| Anesthesia | Vasectomy should be performed with local anesthesia with or without oral sedation. If the patient declines local anesthesia or if the surgeon believes that local anesthesia with or without oral sedation will not be adequate for a particular patient, then vasectomy may be performed with intravenous sedation or general anesthesia. | Clinicians should perform vasectomy with local anesthesia delivered by skin infiltration with a needle and/or jet injector. Topical anesthetic may lessen the pain of local anesthetic infiltration during vasectomy. Clinicians should recommend non-opioid oral analgesics (acetaminophen or non-steroidal anti-inflammatories [NSAID]) for post-operative pain control. |
| Vas Isolation | Isolation of the vas should be performed using a minimally-invasive vasectomy (MIV) technique such as the no-scalpel vasectomy (NSV) technique or other MIV technique. | Surgeons should isolate and expose the vas deferens for vasectomy using a minimally invasive approach such as the no-scalpel vasectomy (NSV) technique. |
| Vas Occlusion | The ends of the vas should be occluded by one of three divisional methods: Mucosal cautery (MC) with fascial interposition (FI) and without ligatures or clips applied on the vas; MC without FI and without ligatures or clips applied on the vas; Open ended vasectomy leaving the testicular end of the vas unoccluded, using MC on the abdominal end and FI; OR by the non-divisional method of extended electrocautery. The divided vas may be occluded by ligatures or clips applied to the ends of the vas, with or without FI, and with or without excision of a short segment of the vas, by surgeons whose personal training and/or experience enable them to consistently obtain satisfactory results with such methods. Routine histologic examination of the excised vas segments is not required. | Surgeons should perform vasectomy with an occlusive technique that combines mucosal cautery (MC) and fascial interposition (FI). Surgeons should not perform vas occlusion using only ligation and excision of a short vas segment. Surgeons may omit routine histological evaluation of excised tissues. |
| Semen Analysis | Men or their partners should use other contraceptive methods until vasectomy success is confirmed by PVSA. To evaluate sperm motility, a fresh uncentrifuged semen sample should be examined within two hours after ejaculation. Patients may stop using other methods of contraception when examination of one well-mixed, uncentrifuged, fresh post-vasectomy semen specimen shows azoospermia or only rare non-motile sperm (RNMS or ≤ 100,000 non-motile sperm/mL). Eight to sixteen weeks after vasectomy is the appropriate time range for the first PVSA. The choice of time to do the first PVSA should be left to the judgment of the surgeon. Vasectomy should be considered a failure if any motile sperm are seen on PVSA at six months after vasectomy, in which case repeat vasectomy should be considered. If >100,000 non-motile sperm/mL persist beyond six months after vasectomy, then trends of serial PVSAs and clinical judgment should be used to decide whether the vasectomy is a failure and whether repeat vasectomy should be considered. | Patients should provide at least one appropriately collected semen sample following vasectomy to confirm occlusive success. An uncentrifuged semen sample following vasectomy may be evaluated in a lab/office setting or by mail-in testing. Patients may discontinue contraception following confirmation of complete azoospermia or ≤100,000 rare non-motile sperm per mL (RNMS) from a single uncentrifuged semen sample evaluated within 2 hours of collection. A sample evaluated >2 hours after collection should show azoospermia to stop contraception. A post-vasectomy semen sample may be submitted as early as 8 weeks following vasectomy. |
Sign up for alerts and stay informed on the latest published guidelines and articles.
Copyright © 2026 Guideline Central, all rights reserved.